Literature DB >> 2981112

Hepatocellular carcinoma detected by iodized oil.

Y Yumoto, K Jinno, K Tokuyama, Y Araki, T Ishimitsu, H Maeda, T Konno, S Iwamoto, K Ohnishi, K Okuda.   

Abstract

This study assesses the diagnostic value of Lipiodol (iodized oil) and computed tomography (CT) in detecting hepatocellular carcinoma (HCC). Twenty-four patients who were suspected of having HCC received injections of a small amount of Lipiodol, along with an antitumor agent, in the hepatic artery following routine celiac angiography. CT scans obtained 7-10 days after Lipiodol administration demonstrated HCC in distinct contrast to the surrounding noncancerous parenchyma. In particular, the CT-Lipiodol procedure disclosed many small HCC lesions that were not shown by celiac angiography, scintigraphy, CT with and without contrast medium enhancement, and ultrasonography. Although this procedure may miss very small or highly fibrotic lesions, it is recommended for patients suspected of having HCC and for patients for whom hepatic resection is being considered.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981112     DOI: 10.1148/radiology.154.1.2981112

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  52 in total

1.  Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma.

Authors:  A Nakayama; H Imamura; Y Matsuyama; H Kitamura; S Miwa; A Kobayashi; S Miyagawa ; S Kawasaki
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

2.  Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.

Authors:  K Yamamoto; M Masuzawa; M Kato; T Okuyama; K Tamura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Outcome of localized hepatocellular carcinoma treated with segmental arterioportal chemoembolization.

Authors:  H Nakamura; H Oi; S Hori; Y Takayasu; S Furui; S Sawada; T Kozuka
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases.

Authors:  G L Rapaccini; M Pompili; E Caturelli; M Anti; A Aliotta; A Cedrone; E Amadei; A Grattagliano; M M Squillante; C Rabitti
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

Review 5.  Arterial embolization in the management of liver metastases.

Authors:  D J Allison; A Booth
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

6.  Staging of hepatocellular carcinoma by ultrasonography, computed tomography, and angiography: the role of CT combined with arterial portography.

Authors:  F Garbagnati; C Spreafico; A Marchianò; M Salvetti; C Segura; G Piragine
Journal:  Gastrointest Radiol       Date:  1991

Review 7.  Advances in neoplastic disease of the liver and biliary tract.

Authors:  P J Johnson; M L Wilkinson; J Karani
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  Intrahepatic distant metastasis and metachronous multicentric occurrence in solitary hepatocellular carcinoma of less than five centimeters in diameter.

Authors:  M Yamamoto; M Matsuda; Y Iimuro; H Fujii; K Nagahori; T Ainota
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma.

Authors:  A Minoyama; M Yoshikawa; M Ebara; H Saisho; N Sugiura; M Ohto
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

10.  Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.

Authors:  Hyo-Sung Kwak; Jeong-Min Lee; Young-Kon Kim; Young Hwan Lee; Chong-Soo Kim
Journal:  Eur Radiol       Date:  2004-09-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.